- Product Details
Keywords
- 267243-28-7
- Canertinib
- 98%
Quick Details
- ProName: 267243-28-7 Canertinib
- CasNo: 267243-28-7
- Molecular Formula: C24H25ClFN5O3
- Appearance: Powder
- Application: Pharma intermediates
- DeliveryTime: 7 days
- PackAge: 1KG -200KG Drum with pallet
- Port: Shanghai port
- ProductionCapacity: 30 Metric Ton/Month
- Purity: 98.0%Min
- Storage: Room temperature
- Transportation: by sea or by air or by courier
- LimitNum: 1 Kilogram
Superiority
Our company was built in 2009 with an ISO certificate.In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.
Our main business covers the fields below:
1.Noble Metal Catalysts (Pt.Pd...)
2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)
3.OLED intermediates (Fluorene,Carbazole,Boric acid...)
4.Customs Synthesis
Our advantage:
1.Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
Details
Canertinib Basic information |
Product Name: | Canertinib |
Synonyms: | N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]acrylamide;CI-1033(Canertinib);PD-183805;Canertinib base;Canetinib;Canertinib (CI-1033);N-[4-(3-chloro-4-fluoroanilino)-7-(3-Morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-en |
CAS: | 267243-28-7 |
MF: | C24H25ClFN5O3 |
MW: | 485.944 |
EINECS: | |
Product Categories: | Inhibitors |
Mol File: | 267243-28-7.mol |
Canertinib Chemical Properties |
Melting point | 188-190° |
Safety Information |
Canertinib Usage And Synthesis |
Uses | Antineoplastic; irreversible pan-erbB tyrosine kinase inhibitor used to treat cancer. |
Uses | CI-1033 is a potent inhibitor of EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, respectively. |
Definition | ChEBI: A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a propenamido group at the 6-position, and a 3-morpholinopropoxy group at the 7-position. |
Canertinib Preparation Products And Raw materials |